Rolf Hohlweg

NNC-112, NNC-687 and NNC-756, new selective and highly potent dopamine D1 receptor antagonists

Peter H. Andersen, Frederik C. Grønvald, Rolf Hohlweg et al. · European Journal of Pharmacology · 1992 · 90 citations · Full text

Functional Selectivity, Medicine, Neuropharmacology +5

Thienopyridine derivatives identified as the first selective, full efficacy, dopamine D1 receptor agonists

Peter H. Andersen, Erik B. Nielson, Jørgen Scheel‐Krüger et al. · European Journal of Pharmacology · 1987 · 56 citations

Molecular Pharmacology, Psychoactive Drug, Functional Selectivity +10

(8‐Naphthalen‐1‐ylmethyl‐4‐oxo‐1‐phenyl‐1,3,8‐triaza‐spiro[4.5]dec‐3‐yl)‐acetic acid methyl ester (NNC 63‐0532) is a novel potent nociceptin receptor agonist

Christian Thomsen, Rolf Hohlweg · British Journal of Pharmacology · 2000 · 42 citations · Full text

Molecular Pharmacology, Fold Selectivity, Biochemistry +15

Antagonistic targeting of the histamine H3 receptor decreases caloric intake in higher mammalian species

Kjell Malmlöf, Sven Hastrup, Birgitte S. Wulff et al. · Biochemical Pharmacology · 2007 · 28 citations

Animal Physiology, Metabolic Syndrome, Obesity +13

Ureas with histamine H3-antagonist receptor activity—A new scaffold discovered by lead-hopping from cinnamic acid amides

Jesper Lau, Claus Jeppesen, Karin Rimvall et al. · Bioorganic & Medicinal Chemistry Letters · 2006 · 28 citations · Full text

Molecular Pharmacology, Pharmaceutical Chemistry, Cinnamic Acid Amides +9